As of January 30, 2026, Swissmedic has updated its guidelines for the maintenance of medical devices,…
Category: Regulatory Affairs
Global updates on medical device regulation and quality.
Swissmedic Authorises Obgemsa: What It Means for Medical Device Manufacturers
As of 30 January 2026, Swissmedic has granted authorisation for Obgemsa, marking a significant milestone in…
Swissmedic Authorises Alyftrek: What You Need to Know
Alyftrek Receives First Authorisation As of 30 January 2026, Alyftrek has been granted its first authorisation…
Swissmedic Intensifies Market Surveillance of Medical Devices: Key Takeaways for Importers
Swissmedic, the Swiss Agency for Therapeutic Products, has conducted a focus campaign on importers of medical…
Swissmedic Introduces Mandatory Quality Standards for Pharmaceuticals: What You Need to Know
The Swiss Agency for Therapeutic Products, Swissmedic, has announced a significant shift in the regulatory landscape…
Swissmedic Approves Extension of Therapeutic Indication for Nubeqa
PUBLISHED: January 29, 2026 Swissmedic has announced the approval of an extension of therapeutic indication for…
Urgent Medical Device Alert: Arixtra Solution for Injection Pre-Filled Syringes Defect Notification
Published on 2026-01-28, a critical medical device alert has been issued for Arixtra solution for injection…
Ocrevus Liver Damage: Swissmedic Update on Ocrelizumab Risks
On January 28, 2026, Swissmedic released a statement regarding Ocrevus (ocrelizumab), a medication used to treat…
Urgent: Ocumont Eye Ointment Recall Due to Missing Braille Labeling
Meta description: Blumont Pharma Limited issues recall for Ocumont Eye Ointment due to missing Braille labeling…
MHRA Issues Latest Safety Roundup for January 2026: Key Updates for Medical Device Users
Published on 2026-01-27T22:01:44.000Z, the Medicines and Healthcare products Regulatory Agency (MHRA) has released its latest safety…